| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |